Literature DB >> 22367268

Symptom clusters in women with relapsing-remitting multiple sclerosis.

Pamela K Newland1, Arleen Fearing, Marguerite Riley, Andrew Neath.   

Abstract

The purpose of this secondary analysis was to investigate the relationships among a set of symptoms (fatigue, depression, impaired cognitive function, sleep disturbance) with pain severity and demographic variables. The sample of 40 women with relapsing-remitting multiple sclerosis completed instruments of pain, fatigue, depression, sleep disturbance, and an objective cognitive measure. Analysis identified one symptom cluster of pain, fatigue, depression, sleep disturbance, and impaired cognitive function, whereas a relationship between that symptom cluster and employment status existed. Pain severity correlated with fatigue, sleep disturbance, depression, and impaired cognitive function. Preliminary findings support providing education on symptoms to women with relapsing-remitting multiple sclerosis to ultimately guide their care.

Entities:  

Mesh:

Year:  2012        PMID: 22367268     DOI: 10.1097/JNN.0b013e3182478cba

Source DB:  PubMed          Journal:  J Neurosci Nurs        ISSN: 0888-0395            Impact factor:   1.230


  11 in total

1.  Pain affects depression through anxiety, fatigue, and sleep in multiple sclerosis.

Authors:  Dagmar Amtmann; Robert L Askew; Jiseon Kim; Hyewon Chung; Dawn M Ehde; Charles H Bombardier; George H Kraft; Salene M Jones; Kurt L Johnson
Journal:  Rehabil Psychol       Date:  2015-01-19

2.  The use of focus groups to characterize symptoms in persons with multiple sclerosis.

Authors:  Pamela K Newland; Florian P Thomas; Marguerite Riley; Louise H Flick; Arleen Fearing
Journal:  J Neurosci Nurs       Date:  2012-12       Impact factor: 1.230

3.  Contribution of symptom clusters to multiple sclerosis consequences.

Authors:  Shahnaz Shahrbanian; Pierre Duquette; Ayse Kuspinar; Nancy E Mayo
Journal:  Qual Life Res       Date:  2014-09-17       Impact factor: 4.147

4.  Comparing CESD-10, PHQ-9, and PROMIS depression instruments in individuals with multiple sclerosis.

Authors:  Dagmar Amtmann; Jiseon Kim; Hyewon Chung; Alyssa M Bamer; Robert L Askew; Salene Wu; Karon F Cook; Kurt L Johnson
Journal:  Rehabil Psychol       Date:  2014-03-24

5.  Case Report: Effect of Antigravity Treadmill Training on Muscle Oxidative Capacity, Muscle Endurance, and Walking Function in a Person with Multiple Sclerosis.

Authors:  T Bradley Willingham; Jonathan Melbourn; Marina Moldavskiy; Kevin K McCully; Deborah Backus
Journal:  Int J MS Care       Date:  2018 Jul-Aug

6.  Symptoms and Association with Health Outcomes in Relapsing-Remitting Multiple Sclerosis: Results of a US Patient Survey.

Authors:  Angela E Williams; Jeffrey T Vietri; Gina Isherwood; Armando Flor
Journal:  Mult Scler Int       Date:  2014-09-23

Review 7.  In Vivo Assessment of Mitochondrial Dysfunction in Clinical Populations Using Near-Infrared Spectroscopy.

Authors:  T Bradley Willingham; Kevin K McCully
Journal:  Front Physiol       Date:  2017-09-14       Impact factor: 4.566

8.  Symptom clusters and quality of life in persons with multiple sclerosis across the lifespan.

Authors:  Stephanie L Silveira; Katie L J Cederberg; Brenda Jeng; E Morghen Sikes; Brian M Sandroff; Catherine D Jones; Robert W Motl
Journal:  Qual Life Res       Date:  2020-11-05       Impact factor: 4.147

9.  Onset Symptom Clusters in Multiple Sclerosis: Characteristics, Comorbidities, and Risk Factors.

Authors:  Vladeta Ajdacic-Gross; Nina Steinemann; Gábor Horváth; Stephanie Rodgers; Marco Kaufmann; Yanhua Xu; Christian P Kamm; Jürg Kesselring; Zina-Mary Manjaly; Chiara Zecca; Pasquale Calabrese; Milo A Puhan; Viktor von Wyl
Journal:  Front Neurol       Date:  2021-07-06       Impact factor: 4.003

10.  Do physical activity and social cognitive theory variable scores differ across symptom cluster severity groups in multiple sclerosis?

Authors:  Stephanie L Silveira; Katie L J Cederberg; Brenda Jeng; E Morghen Sikes; Brian M Sandroff; Catherine D Jones; Robert W Motl
Journal:  Disabil Health J       Date:  2021-06-29       Impact factor: 4.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.